Ligand Pharmaceuticals Inc (LGND)
Equity Ratio
44.26%
Quarterly · Period ending:
LGND Equity Ratio
Latest reported44.26%period ending
Latest reported44.26%period ending
LGND Quarterly Equity Ratio (83.10% → 44.26%)
Latest values, visible window
High-resolution chart · PNG
LGND equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 44.2622% | |
| 65.0949% | |
| 65.1793% | |
| 64.3411% | |
| 87.3419% | |
| 87.8621% | |
| 88.1782% | |
| 88.0938% | |
| 89.4729% | |
| 88.2535% | |
| 89.0369% | |
| 86.827% | |
| 87.7045% | |
| 79.6864% | |
| 78.3414% | |
| 77.6979% | |
| 74.5493% | |
| 71.7701% | |
| 63.2834% | |
| 63.7587% | |
| 62.6067% | |
| 57.5884% | |
| 52.0834% | |
| 55.9401% | |
| 55.9162% | |
| 55.813% | |
| 51.3228% | |
| 54.9657% | |
| 57.7995% | |
| 56.4253% | |
| 44.4886% | |
| 33.2196% | |
| 33.3541% | |
| 65.8804% | |
| 62.3896% | |
| 64.1309% | |
| 63.9678% | |
| 63.3259% | |
| 61.646% | |
| 61.6433% | |
| 63.5403% | |
| 63.9147% | |
| 57.0096% | |
| 56.0056% | |
| 22.658% | |
| 13.3529% | |
| 10.1996% | |
| 16.2963% | |
| 64.2683% | |
| 61.6293% | |
| 47.38% | |
| 44.0758% | |
| 39.4372% | |
| 31.1052% | |
| 25.4028% | |
| 21.7781% | |
| 17.6415% | |
| 17.2123% | |
| 7.0666% | |
| 1.9328% | |
| 4.1802% | |
| 3.7338% | |
| -6.4175% | |
| -8.386% | |
| 2.0816% | |
| 1.6053% | |
| 2.6402% | |
| -8.1111% | |
| -9.4902% | |
| -10.5296% | |
| -6.0456% | |
| 1.3275% | |
| 11.8864% | |
| 14.756% | |
| 16.8025% | |
| 12.4288% | |
| 14.9828% | |
| 10.9377% | |
| 8.3888% | |
| -108.3337% | |
| -83.4121% | |
| -77.7162% | |
| -35.0961% | |
| -35.424% | |
| -33.9351% | |
| -29.9936% | |
| -22.654% | |
| 14.1894% | |
| 16.823% | |
| 20.5212% | |
| 23.4778% | |
| 22.946% | |
| 11.923% | |
| 15.7657% | |
| 27.3513% | |
| 68.3451% | |
| 68.1608% | |
| 26.0895% | |
| -49.2666% | |
| -44.6077% |